Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy With New Oral Anticoagulants in Patients With Atrial Fibrillation and Renal Impairment

NCT02222090 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT02222090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02222090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy With New Oral Anticoagulants in Patients With Atrial Fibrillation and Renal Impairment
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2014
Completion date
July 31, 2016
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, non-valvular atrial fibrillation